FDA Advisory Panel Recommends Broader Access to Popular Healing Compound

Washington, Thursday, 23 July 2026.
On July 23, 2026, an FDA panel voted 8–6 to recommend BPC-157 for pharmacy compounding, overriding agency scientists who warned of a severe lack of human safety data.